65.51 USD
↘ 0.14 (0.21%)PRE MARKET (AS OF 05:37 AM EDT)
Shares of PTC Therapeutics, Inc. (PTCT) are trading at $65.51. Both sides of the analysis point lower: technicals flash "Strong Sell" and fundamentals confirm with a "Sell" reading. Key drivers include a concerning Altman Z-Score in the distress zone, exceptional Return on Equity (23.2%) and a bearish Death Cross on the long-term moving averages. PTCT is fairly valued relative to its sector peers based on current multiples.
Technical & fundamental data as of Sep 15, 2026.